Advanced Filters
noise

Lille Cidex, France Clinical Trials

A listing of Lille Cidex, France clinical trials actively recruiting patients volunteers.

Found 593 clinical trials

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

The goal of this pilot, phase 2, single-arm, clinical trial is to assess the antiretroviral combination Doravirine (DOR)/Lamivudine (3TC)/Tenofovir Disproxyl Fumarate (TDF) in participants with suppressed HIV who previously developed M184V/I mutation that confers resistance to 3TC. The main question it aims to answer is to explore the rate of …

18 years of age All Phase 2
M Matthieu ALLEZ, MD

Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

MAINTAIN-POP is a Phase 2, randomised, double-blind, placebo-controlled, multicenter study of the impact of oral administration of EXL01 in the prevention of post-operative endoscopic recurrence of Crohn's disease after surgery. Approximately 80 eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with or without SoC treatment (based …

18 years of age All Phase 2
E Emmanuel Chartier-Kastler

A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)

Prospective, multicenter, single-arm study

22 years of age Male Phase N/A
R Raphaelle MAUDINAS, MD

Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence

Oesophageal atresia (OAEA), a malformation of the oesophagus present from birth, is characterized by the interruption of the continuity of the oesophagus, which then ends in a cul-de-sac. (Source: Fimatho) An operation is then required to restore continuity to the esophagus. Although this operation enables the vast majority of children …

13 - 14 years of age All Phase N/A
L Laurent MORTIER, PhD

Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma

Locally advanced basal cell carcinoma (BCC) are large BCCs or BCCs located in areas subject to functional and aesthetic risk following surgery or radiotherapy. In these particular situations, surgery and radiotherapy are sometimes not appropriate, and Sonic Hedgehog inhibitors (SHHi) (Vismodegib and Sonidegib) can be proposed. SHHi are effective treatments …

18 years of age All Phase 2
G GAMELIN François-Xavier, PhD

Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users

The endocannabinoid system (ECS) is a complex endogenous signaling system made up of transmembrane cannabinoid receptors (CB1 and CB2 receptors), their endogenous lipid-derived ligands (the endocannabinoids - eCBs), and enzymes for ligand biosynthesis and degradation. Interestingly, exercise increase plasma AEA, one of the most famous endocannabinoid. This increase could be …

18 - 35 years of age All Phase N/A
J Jean-Marie LE BORGNE, MD

Ziconotide for Non-cancer Pain by Intrathecal Administration

Although ziconotide's marketing authorization does not restrict its use to a given type of pain, the drug has been used mainly in cancer patients. Most data on ziconotide-based intrathecal (IT) treatment has therefore been obtained in this population, for whom the drug's place is clearly documented (national and international recommendations). …

18 years of age All Phase N/A
A Aghiles HAMROUN, MD, PhD

Reasoning Enrichment With Feedback From IA in NEphrology Trial

The goal of this clinical trial is to learn how artificial intelligence (AI) may help doctors make diagnoses in kidney medicine. The researchers want to know whether an AI tool called a large language model (LLM) can help doctors choose the correct diagnosis more often and feel more confident in …

18 years of age All Phase N/A
C CHRYSTELE RUBOD DIT GUILLET,

ENDOMETRIOSIS - MRI

Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to …

18 - 50 years of age Female Phase N/A
S Stéphanie Martinez, Dr

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

The hypothesize is that tepotinib is more effective than the investigator's choice of treatment in patients with MET-mutated NSCLC who have progressed after at least one first-line treatment. The main benefit concerns patient access to tepotinib. There is currently no access to a new-generation MET TKI in France for METex14 …

18 years of age All Phase 3

Simplify language using AI